The most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.
Idunox has raised $4K in total funding. The most recent round was Grant. The last funding was announced in August 2024.
Idunox's investors include Venture Kick, CSEM, DayOne accelerator.
Idunox is headquartered in Allschwil, Switzerland.
The most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.
Idunox is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Idunox — Funding & Investors." VCBacked, August 23, 2024, https://www.vcbacked.co/company/idunox. Accessed July 21, 2026.
VCBacked. (2024). Idunox — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/idunox
{{cite web |title=Idunox — Funding & Investors |url=https://www.vcbacked.co/company/idunox |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated